Victrex (LON:VCT – Get Rating) had its target price decreased by Jefferies Financial Group from GBX 1,900 ($23.63) to GBX 1,590 ($19.78) in a research note released on Tuesday morning, MarketBeat reports. Jefferies Financial Group currently has a hold rating on the stock.
Separately, Barclays decreased their price target on shares of Victrex from GBX 2,310 ($28.73) to GBX 2,280 ($28.36) and set an overweight rating on the stock in a report on Friday, April 21st.
Victrex Stock Performance
LON:VCT opened at GBX 1,545 ($19.22) on Tuesday. The business’s 50-day moving average price is GBX 1,598.71 and its two-hundred day moving average price is GBX 1,692.37. Victrex has a twelve month low of GBX 1,479 ($18.40) and a twelve month high of GBX 1,953.15 ($24.29). The stock has a market cap of £1.34 billion, a P/E ratio of 1,884.15, a PEG ratio of 1.80 and a beta of 0.83. The company has a quick ratio of 1.99, a current ratio of 3.37 and a debt-to-equity ratio of 9.01.
Victrex Cuts Dividend
Insider Transactions at Victrex
In other Victrex news, insider Martin Court acquired 600 shares of the stock in a transaction dated Tuesday, May 16th. The stock was purchased at an average cost of GBX 1,530 ($19.03) per share, for a total transaction of £9,180 ($11,417.91). In related news, insider Ian Melling acquired 1,000 shares of the firm’s stock in a transaction dated Wednesday, May 10th. The shares were purchased at an average price of GBX 1,518 ($18.88) per share, for a total transaction of £15,180 ($18,880.60). Also, insider Martin Court bought 600 shares of the business’s stock in a transaction dated Tuesday, May 16th. The stock was purchased at an average price of GBX 1,530 ($19.03) per share, for a total transaction of £9,180 ($11,417.91). In the last ninety days, insiders acquired 1,609 shares of company stock worth $2,450,085. 1.64% of the stock is currently owned by insiders.
Victrex Company Profile
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company operates through two segments, Industrial and Medical. It develops PEEK and PAEK polymer solutions, and semi-finished and finished parts. The company also offers specialist solutions for medical device manufacturers; sells thermoplastic polymer components; and engages in trading activities.
See Also
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.